We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: news

Advancing Gender Equity in Ophthalmology: The Impact of Virtual Oral Board Exams on Workforce Representation

MedXY Editorial Team•Oct 11, 2026•news
Board CertificationGender EquityophthalmologyVirtual Exams

Highlight

This study identifies a marked increase in the proportion of female oral board examiners in ophthalmology coinciding with a shift to virtual exam administration. Despite this, female representation among examinees showed no significant change during the same period. Flexibility afforded by virtual platforms may facilitate greater workforce inclusion, emphasizing the importance of adaptive certification policies.

Study Background

Equity and diversity within medical specialties have garnered increased attention due to their relevance in optimizing workforce effectiveness and patient care. Ophthalmology, like other medical specialties, has historically faced gender disparities, particularly in senior roles such as board examiners who influence professional standards. The American Board of Ophthalmology (ABO) oral board examination is a critical credentialing process for ophthalmologists in the United States. Understanding demographic shifts among examiners and examinees is essential as diversity may impact educational dynamics, professional mentorship, and broader workforce inclusivity.

Study Design

This retrospective cohort study analyzed demographic data from the ABO and the Association of American Medical Colleges (AAMC) spanning 2011 to 2024. The primary focus was on gender distribution among oral board examiners and examinees. Key examiner variables included gender, years of clinical experience, year of initial certification, and average examiner score. Examinee variables comprised gender, years since residency graduation, and examination outcomes (pass versus fail). Logistic regression models assessed temporal trends in examiner and examinee gender proportions, with particular attention to differences before and after the 2020 transition from in-person to virtual oral exams.

Key Findings

The proportion of female examiners increased significantly over the study period, with the most notable rise following the 2020 pivot to a virtual exam format. Female examiner representation expanded from 31.3% in 2019 (95% CI: 24.1%-38.4%) to 49.1% in 2024 (95% CI: 43.8%-54.4%), yielding a statistically significant p-value of less than 0.001. This suggests that virtual exam administration may reduce logistical barriers such as travel and schedule inflexibility, thereby enabling greater participation by women in examiner roles.

In contrast, the percentage of female examinees remained relatively stable, measuring 41.7% in 2019 (95% CI: 37.6%-45.8%) and 37.5% in 2024 (95% CI: 33.0%-42.0%), with a p-value of 0.019 indicating minor but statistically significant variation without an upward trend. This stability in examinee gender distribution indicates persistent gender dynamics in ophthalmology training and certification candidacy.

Expert Commentary

These findings highlight the transformative potential of virtual technology in advancing equity in medical certification processes. Increased female representation among examiners may contribute to more inclusive assessment perspectives and mentorship opportunities for examinees. Nonetheless, the study is limited by its observational design and lack of granular data on other diversity dimensions such as race/ethnicity or socioeconomic background. Additionally, causality between virtual exam administration and increased female participation cannot be definitively established. Further qualitative studies assessing examiner and examinee experiences may elucidate underlying facilitators and barriers to participation.

Conclusion

The transition to virtual oral board examinations is associated with a significant increase in the representation of women among American Board of Ophthalmology oral board examiners, suggesting improved inclusivity linked to scheduling flexibility. Female examinee representation remained stable, underscoring ongoing challenges in recruiting and certifying women ophthalmologists. Continued efforts to integrate flexible certification processes and targeted initiatives aimed at enhancing gender diversity at trainee and examiner levels are warranted to foster equity in ophthalmology.

Funding and ClinicalTrials.gov

No external funding was reported for this retrospective cohort study. The study was not registered on ClinicalTrials.gov as it involved analysis of pre-existing data without patient interventions.

References

1. Woreta FA, Aamir FB, Ali M, Culican S, Wang J, Dun C, Martin B, Schnabel S, Bartley GB. Workforce Representation in Ophthalmology Oral Board Examiners and Examinees. American Journal of Ophthalmology. 2026 Jun 25;290:252-257. PMID: 42349536.
2. Association of American Medical Colleges. Diversity in Medicine: Facts and Figures 2019.
3. Esfandiari H, Lee AG. Gender Disparities in Academic Ophthalmology and Vision Science Leadership. Ophthalmology. 2020;127(3):299-301.
4. Carr PL, et al. Effect of institutional culture and policies on women’s academic careers in academic medicine. JAMA. 2018;320(23):2459-2460.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

When Is High-Level Disinfection Needed for Reusable Ophthalmic Devices? A Multisociety Position Paper ExplainedA multisociety task force finds routine high-level disinfection (HLD) of reusable ophthalmic devices unnecessary in most clinics, recommends targeted HLD only for higher-risk encounters, and urges alignment of regulations with evidence.Oct 17, 2026Individualized High-Fluence Corneal Cross-Linking for Ultrathin Keratoconus: Insights from the ELZA-sub400 ProtocolThe ELZA-sub400 protocol demonstrates safe and effective high-fluence corneal cross-linking tailored for ultrathin keratoconus corneas, halting ectasia progression in most treated eyes at 12 months with no endothelial damage.Oct 11, 2026Evaluating Aflibercept With Reduced-Fluence Photodynamic Therapy in Polypoidal Choroidal Vasculopathy: Insights from Longitudinal OCT AngiographyThis randomized trial compares aflibercept monotherapy versus combined with reduced-fluence photodynamic therapy for PCV, highlighting OCTA metrics that predict polypoidal lesion closure and treatment response over 52 weeks.Oct 9, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Cardiology
Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Effective Retinal Detachment Prevention in Type 2 Stickler Syndrome Using Cambridge Prophylactic Cryotherapy
Prophylactic cryotherapy significantly lowers retinal detachment risk in Type 2 Stickler syndrome, demonstrating safety and efficacy in a large national cohort study.
Sep 29, 2026
LYNX-1 Phase 3 Trial: Phentolamine Ophthalmic Solution for Dim Light Vision DisturbancesThe Phase 3 LYNX-1 trial demonstrates that 0.75% phentolamine ophthalmic solution improves mesopic low-contrast visual acuity and reduces photic symptoms in patients with dim light vision disturbances, including those post-keratorefractiveSep 20, 2026
Distinct Molecular and Clinical Profiles of USH2A-Associated Retinitis Pigmentosa in Korean Patients: Implications for Targeted TherapyThis study elucidates the unique East Asian-specific genetic variants and clinical progression of USH2A-associated retinitis pigmentosa in Koreans, highlighting the potential for exon 13-targeted treatments.Sep 19, 2026